secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001558370-23-012895
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kala Pharmaceuticals changes name to KALA BIO, Inc.; ticker KALA unchanged
--------------------------------------------------------------------------

- Effective August 2, 2023, name changed from Kala Pharmaceuticals, Inc. to KALA BIO, Inc.
- Ticker symbol remains KALA on Nasdaq; trading under new name starts August 3, 2023.
- Stockholder rights unaffected; CUSIP unchanged.
- Board approved the name change under Delaware law; amended certificate and bylaws filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/0001558370-23-012895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/kala-20230802x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-012895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer